// App-Quantinova.ai

AEP671 : To score or not to score? Is Ki-67 analysis worthwhile in pituitary neuroendocrine tumours?

Researchers

Presenter

  • Paul Benjamin Loughrey

Principal Investigators

  • Stephanie Craig

  • Brian Herron

  • Fatima Abdullahi Sidi

  • Stephen McQuaid

  • Paul Kelly

  • Matt Humphries

  • Eileen Parkes

  • Darragh McArt

  • Steven Hunter

  • Marta Korbonits

  • Jacqueline James

Medical Centers

  • Queen’s University, Patrick G Johnston Centre for Cancer Research, Belfast, United Kingdom

  • Royal Victoria Hospital, Cellular Pathology, Belfast, United Kingdom

  • University of Oxford, Department of Oncology, Oxford, United Kingdom

  • William Harvey Research Institute, Centre for Endocrinology, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • p53

  • Proliferation marker protein Ki-67

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved